Surety Medicine

 Surety Medicine

Last Updated: January 21, 2025

​​​​​​​​​​​​​​​​​​​Surety medicine focuses on protecting the health of the personnel who deal with nuclear, biological or chemical materials, and on medical requirement compliance to help ensure the security of the materials and the work force.


February 2025 Surety Medicine Teleconference             

​Constructing Most Probable Events
for Laboratory Operations

​Wednesday, 19 February 2024 will bring the second monthly Surety Medicine Teleconference of 2025, at 1 pm (1300 hrs) Eastern Time.  The topic for February is "Constructing Most Probable Events for Laboratory Operations."  The presenter will be an Occupational Medicine Physician from the U.S. Army Office of The Surgeon General Surety Medicine Program.

To request additional information, email the Army Surety Medicine Branch. 

-----------------------------------------------------------------------------------------------

FY25 Surety Medicine Teleconferences

Presentation Title

                             Date

​Constructing Most Probable Events for                                                      02/19/2025
​L
aboratory Operations​

The Dental Officer's Perspective: Screening Records                               03/19/2025​
and Soldiers for PRP Enrollment and Retention 

Pharmaceutical Based Agents: Medical Surveillance                                04/16/2025
and Treatment Considerations 

Aging, Cognitive Decline, and the PRP: Clinic-based                                 05/21/2025​
Screening Approaches

Hearing in Noise Testing                                                                                 06/18/2025

Obesity, Cardiovascular Fitness, and Personal                                            07/16/2025
Protective Equipment: How Fat is Too Fat? 

Red Blood Cell Cholinesterase Monitoring: What                                       08/20/2025
Every CMA Should Know 

Permanent Limitations and the PRP                                                               09/17/2025

________________________________________________________

--ALERT--


 NERVE AGENT ANTIDOTE SHELF LIFE
 EXTENSION PROGRAM

Specific lots of DuoDote(R) combined nerve agent antidote auto-injectors were approved for shelf life extensions beyond labeled expiration dates; all of these have now expired.  

NO PREVIOUSLY EXTENDED NERVE AGENT
ANTIDOTES ARE NOW APPROVED FOR USE.

Previously, the U.S. Food and Drug Administration (FDA) provided extended expiry dates for specific lots of AtroPen (atropine), CANA (diazepam), DuoDote, morphine sulfate, and pralidoxime chloride auto-injectors. However, because no further expiry dating extensions of these lots are possible, FDA is alerting civilian health care professionals and emergency responders that all of these extended lots are no longer useable and should be properly disposed of.

Complete FDA information related to the auto-injector shelf life extension program can be found at this
 FDA Drug Sa​fety Page.